Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.
American Heart Journal|March 3, 2009
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of riskCampbell D Joyner, Ron J G Peters, Rizwan Afzal, et al.
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology|October 30, 2012
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevationShamir R Mehta, Sanjit S Jolly, John Cairns, et al.
JACC. Cardiooncology|August 24, 2023
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewDarryl P Leong, Filipe Cirne, Nazanin Aghel, et al.
Platelets|July 3, 2025
Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS studyTony Haddad, Osama Elkhateeb, Lawrence Title, et al.
Circulation. Cardiovascular Interventions|August 28, 2019
Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY StentsDean J Kereiakes, Stephan Windecker, R Lee Jobe, et al.
European Heart Journal|December 18, 2007
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatmentJonas Oldgren, Lars Wallentin, Rizwan Afzal, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.
American Heart Journal|March 3, 2009
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of riskCampbell D Joyner, Ron J G Peters, Rizwan Afzal, et al.
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology|October 30, 2012
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevationShamir R Mehta, Sanjit S Jolly, John Cairns, et al.
JACC. Cardiooncology|August 24, 2023
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: <i>JACC: CardioOncology</i> State-of-the-Art ReviewDarryl P Leong, Filipe Cirne, Nazanin Aghel, et al.
Platelets|July 3, 2025
Differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chronic coronary syndrome patients: the DEFINE CCS studyTony Haddad, Osama Elkhateeb, Lawrence Title, et al.
Circulation. Cardiovascular Interventions|August 28, 2019
Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY StentsDean J Kereiakes, Stephan Windecker, R Lee Jobe, et al.
European Heart Journal|December 18, 2007
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatmentJonas Oldgren, Lars Wallentin, Rizwan Afzal, et al.
Pageof 22